The DOI matches its Crossref record; 1,070 of the 1,070 references it cites were found in a registry or an index.
Role of Oxidative Modifications in Atherosclerosis
Abstract
This review focuses on the role of oxidative processes in atherosclerosis and its resultant cardiovascular events. There is now a consensus that atherosclerosis represents a state of heightened oxidative stress characterized by lipid and protein oxidation in the vascular wall. The oxidative modification hypothesis of atherosclerosis predicts that low-density lipoprotein (LDL) oxidation is an early event in atherosclerosis and that oxidized LDL contributes to atherogenesis. In support of this hypothesis, oxidized LDL can support foam cell formation in vitro, the lipid in human lesions is substantially oxidized, there is evidence for the presence of oxidized LDL in vivo, oxidized LDL has a number of potentially proatherogenic activities, and several structurally unrelated antioxidants inhibit atherosclerosis in animals. An emerging consensus also underscores the importance in vascular disease of oxidative events in addition to LDL oxidation. These include the production of reactive oxygen and nitrogen species by vascular cells, as well as oxidative modifications contributing to important clinical manifestations of coronary artery disease such as endothelial dysfunction and plaque disruption. Despite these abundant data however, fundamental problems remain with implicating oxidative modification as a (requisite) pathophysiologically important cause for atherosclerosis. These include the poor performance of antioxidant strategies in limiting either atherosclerosis or cardiovascular events from atherosclerosis, and observations in animals that suggest dissociation between atherosclerosis and lipoprotein oxidation. Indeed, it remains to be established that oxidative events are a cause rather than an injurious response to atherogenesis. In this context, inflammation needs to be considered as a primary process of atherosclerosis, and oxidative stress as a secondary event. To address this issue, we have proposed an “oxidative response to inflammation” model as a means of reconciling the response-to-injury and oxidative modification hypotheses of atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ushio-Fukai, M., Tang, Y., Fukai, T., Dikalov, S. I., Ma, Y., Fujimoto, M., Quinn, M. T., Pagano, P. J., Johnson, C., & Alexander, R. W. (2002) · Circulation Research · doi:10.1161/01.res.0000046227.65158.f8 · Cited by 463
RetractedAtherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Free radicals in biology and medicine
(1991) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
On the nature of allosteric transitions: A plausible model
Monod, J., Wyman, J., & Changeux, J.-P. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80285-6 · Cited by 8,825
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Cited by
Items 101–120 of 120
Nitric oxide and geriatrics: Implications in diagnostics and treatment of the elderly
Ashley C, T., Mayank, A., & Nathan S, B. (2012) · Journal of Geriatric Cardiology · doi:10.3724/sp.j.1263.2011.00230 · Cited by 101
Drobiova, H., Thomson, M., Al-Qattan, K., Peltonen-Shalaby, R., Al-Amin, Z., & Ali, M. (2011) · Evidence-Based Complementary and Alternative Medicine · doi:10.1093/ecam/nep011 · Cited by 91
Nox4 Is a Major Source of Superoxide Production in Human Brain Pericytes
Kuroda, J., Ago, T., Nishimura, A., Nakamura, K., Matsuo, R., Wakisaka, Y., Kamouchi, M., & Kitazono, T. (2014) · Journal of Vascular Research · doi:10.1159/000369930 · Cited by 73
Kefiran Reduces Atherosclerosis in Rabbits Fed a High Cholesterol Diet
Uchida, M., Ishii, I., Inoue, C., Akisato, Y., Watanabe, K., Hosoyama, S., Toida, T., Ariyoshi, N., & Kitada, M. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.4812 · Cited by 65
Ueda, S., Yamagishi, S.-I., Matsumoto, Y., Fukami, K., & Okuda, S. (2007) · Clinical and Experimental Nephrology · doi:10.1007/s10157-007-0471-x · Cited by 65
Romani, A., Lapucci, C., Cantini, C., Ieri, F., Mulinacci, N., & Visioli, F. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf062335r · Cited by 60
Pardo-Andreu, G. L., Paim, B. A., Castilho, R. F., Velho, J. A., Delgado, R., Vercesi, A. E., & Oliveira, H. C. F. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.03.005 · Cited by 58
Functionality of HDL: Antioxidation and Detoxifying Effects
Karlsson, H., Kontush, A., & James, R. W. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-319-09665-0_5 · Cited by 55
Cao, Z., Zhu, H., Zhang, L., Zhao, X., Zweier, J. L., & Li, Y. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100809 · Cited by 56
Stanley, N., Stadler, N., Woods, A. A., Bannon, P. G., & Davies, M. J. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.12.031 · Cited by 51
Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction
Abdo, A. I., Rayner, B. S., van Reyk, D. M., & Hawkins, C. L. (2017) · Redox Biology · doi:10.1016/j.redox.2017.08.004 · Cited by 51
Skin Redox Balance Maintenance: The Need for an Nrf2-Activator Delivery System
Ben-Yehuda Greenwald, M., Ben-Sasson, S., Bianco-Peled, H., & Kohen, R. (2016) · Cosmetics · doi:10.3390/cosmetics3010001 · Cited by 49
Antiatherosclerotic Effect of an Antibody That Binds to Extracellular Matrix Glycosaminoglycans
Soto, Y., Acosta, E., Delgado, L., Pérez, A., Falcón, V., Bécquer, M. A., Fraga, Á., Brito, V., Álvarez, I., Griñán, T., et al. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.238659 · Cited by 41
Denniss, S. G. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.2008.04.01.213 · Cited by 37
RNA-binding proteins in vascular inflammation and atherosclerosis
Sachse, M., Tual-Chalot, S., Ciliberti, G., Amponsah-Offeh, M., Stamatelopoulos, K., Gatsiou, A., & Stellos, K. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.01.008 · Cited by 29
Nitro-Oxidative Stress Biomarkers in Active and Inactive Men
Bjork, L., Jenkins, N., Witkowski, S., & Hagberg, J. (2012) · International Journal of Sports Medicine · doi:10.1055/s-0032-1301891 · Cited by 27
6-mo aerobic exercise intervention enhances the lipid peroxide transport function of HDL
Tiainen, S., Luoto, R., Ahotupa, M., Raitanen, J., & Vasankari, T. (2016) · Free Radical Research · doi:10.1080/10715762.2016.1252040 · Cited by 23
Khan, T. G., Ginsburg, D., & Emmer, B. T. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100248 · Cited by 21
Nrf2-Mediated Dichotomy in the Vascular System: Mechanistic and Therapeutic Perspective
Wu, W., Hendrix, A., Nair, S., & Cui, T. (2022) · Cells · doi:10.3390/cells11193042 · Cited by 20
Mahmood, T., Miles, J. R., Minnier, J., Tavori, H., DeBarber, A. E., Fazio, S., & Shapiro, M. D. (2024) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2023.10.009 · Cited by 9
Metadata
- Authors
- Stocker, R., & Keaney, J. F.
- Venue
- Physiological Reviews
- Publisher
- American Physiological Society
- Published
- 2004-10
- Volume
- 84
- Issue
- 4
- Pages
- 1381-1478
- ISSN
- 0031-9333 (ISSN-L)
- 1522-1210
- OpenAlex
- W1976616659
- Cited by
- 2,624
- References
- 1,070
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.